SummerBio Launches High-Volume, Affordable Molecular Test to Detect COVID-19
Summary
The SummerBio SARS-CoV-2 Test is easily administered by a healthcare professional using a gentle nasal swab, and individual results are usually ready within 24 hours of collection and automatically sent to customers in real-time. Srini Ananth, Investment Director at Intel Capital, and Ajit Singh, Partner at Artiman Ventures, have joined the SummerBio board. SummerBio’s CEO, Guido Baechler, who spent two decades with Roche Molecular Diagnostics, said, “Broad and rapid testing for COVID-19 is absolutely critical for everyone to more safely return to school, work and a more normal life. To date, SummerBio has processed more than 130,000 tests and provided results on time,” said Austin Beutner, Superintendent of Los Angeles Unified School District. “SummerBio is advancing low cost, high-volume RT-PCR testing for COVID-19 and has streamlined the entire process, making it easier and faster for people to obtain results,” said Nick Washburn, Senior Managing Director at Intel Capital.